Paul S Corotto1, Hyojung Kang2, Brianna Massaro3, William C Harding4, Neil R Shah4, Sneha Gadi4, Kenneth Bilchick5, Sula Mazimba5, Younghoon Kwon5. 1. Lehigh Valley Heart Institute, LVPG Cardiology, Allentown, Pennsylvania. 2. Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Champaign, Illinois. 3. University of Virginia, Charlottesville, Virginia. 4. Department of Medicine, University of Virginia, Charlottesville, Virginia. 5. Department of Medicine, Cardiovascular Division, University of Virginia, Charlottesville, Virginia.
Abstract
INTRODUCTION: Obstructive sleep apnea (OSA) is a highly prevalent sleep disorder with important cardiovascular implications. Left atrial abnormality can be identified by electrocardiographic P-wave morphology and is considered an important risk for atrial fibrillation (AF) and stroke, both of which have been associated with OSA. We hypothesized that severity of OSA would be associated with more abnormal electrocardiographic P-wave morphology as indicated by P-wave terminal force in V1 (PTFV1 ) and P-wave area in V1 (PWAV1 ). METHODS: Patients who underwent clinically indicated polysomnography and had 12-lead ECG were identified through medical record review. Logistic regression was used to determine the associations between the measures of OSA severity (apnea hypopnea index [AHI] and mean nocturnal oxygen [O2 ] saturation) and abnormal PTFV1 and PWAV1 (defined by >75% percentile value of the studied cohort) adjusting for age, sex, body mass index, and hypertension. RESULTS: A total of 261 patients (mean age: 57 years old, male: 52%) were included in the study. Multivariate analysis showed that AHI was associated with abnormal PTFV1 (>7,280 µV ms) and PWAV1 (>1,000 µV ms; OR: 1.5; 95% CI [1.1, 2.0], p = 0.008; OR: 1.5 [1.1, 2.1], p = 0.005 per 1 SD increase in AHI, respectively). Mean O2 saturation was associated with abnormal PWAV1 (OR: 0.72 [0.54, 0.98], p = 0.03). Results remained unchanged after excluding patients taking AV nodal blocking agents. CONCLUSION: In a sleep clinic cohort, there was significant association between OSA severity and ECG-defined left atrial abnormality.
INTRODUCTION: Obstructive sleep apnea (OSA) is a highly prevalent sleep disorder with important cardiovascular implications. Left atrial abnormality can be identified by electrocardiographic P-wave morphology and is considered an important risk for atrial fibrillation (AF) and stroke, both of which have been associated with OSA. We hypothesized that severity of OSA would be associated with more abnormal electrocardiographic P-wave morphology as indicated by P-wave terminal force in V1 (PTFV1 ) and P-wave area in V1 (PWAV1 ). METHODS:Patients who underwent clinically indicated polysomnography and had 12-lead ECG were identified through medical record review. Logistic regression was used to determine the associations between the measures of OSA severity (apnea hypopnea index [AHI] and mean nocturnal oxygen [O2 ] saturation) and abnormal PTFV1 and PWAV1 (defined by >75% percentile value of the studied cohort) adjusting for age, sex, body mass index, and hypertension. RESULTS: A total of 261 patients (mean age: 57 years old, male: 52%) were included in the study. Multivariate analysis showed that AHI was associated with abnormal PTFV1 (>7,280 µV ms) and PWAV1 (>1,000 µV ms; OR: 1.5; 95% CI [1.1, 2.0], p = 0.008; OR: 1.5 [1.1, 2.1], p = 0.005 per 1 SD increase in AHI, respectively). Mean O2 saturation was associated with abnormal PWAV1 (OR: 0.72 [0.54, 0.98], p = 0.03). Results remained unchanged after excluding patients taking AV nodal blocking agents. CONCLUSION: In a sleep clinic cohort, there was significant association between OSA severity and ECG-defined left atrial abnormality.
Authors: Shun Kohsaka; Robert R Sciacca; Kenichi Sugioka; Ralph L Sacco; Shunichi Homma; Marco R Di Tullio Journal: Stroke Date: 2005-10-06 Impact factor: 7.914
Authors: Younghoon Kwon; Sina A Gharib; Mary L Biggs; David R Jacobs; Alvaro Alonso; Daniel Duprez; Joao Lima; Gen-Min Lin; Elsayed Z Soliman; Reena Mehra; Susan Redline; Susan R Heckbert Journal: Thorax Date: 2015-05-18 Impact factor: 9.139
Authors: Hooman Kamel; Traci M Bartz; W T Longstreth; Peter M Okin; Evan L Thacker; Kristen K Patton; Phyllis K Stein; Rebecca F Gottesman; Susan R Heckbert; Richard A Kronmal; Mitchell S V Elkind; Elsayed Z Soliman Journal: Stroke Date: 2015-02-12 Impact factor: 7.914
Authors: Maria E Otto; Marek Belohlavek; Abel Romero-Corral; Apoor S Gami; Gregory Gilman; Anna Svatikova; Raouf S Amin; Francisco Lopez-Jimenez; Bijoy K Khandheria; Virend K Somers Journal: Am J Cardiol Date: 2007-03-20 Impact factor: 2.778
Authors: Paul E Peppard; Terry Young; Jodi H Barnet; Mari Palta; Erika W Hagen; Khin Mae Hla Journal: Am J Epidemiol Date: 2013-04-14 Impact factor: 4.897
Authors: Jonathan W Weinsaft; Jonathan D Kochav; Jiwon Kim; Sergey Gurevich; Samuel C Volo; Anika Afroz; Maya Petashnick; Agnes Kim; Richard B Devereux; Peter M Okin Journal: PLoS One Date: 2014-06-05 Impact factor: 3.240
Authors: Paul S Corotto; Hyojung Kang; Brianna Massaro; William C Harding; Neil R Shah; Sneha Gadi; Kenneth Bilchick; Sula Mazimba; Younghoon Kwon Journal: Ann Noninvasive Electrocardiol Date: 2019-02-23 Impact factor: 1.468